De Burlo Group Inc Astrazeneca PLC Transaction History
De Burlo Group Inc
- $741 Million
- Q4 2024
A detailed history of De Burlo Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, De Burlo Group Inc holds 13,041 shares of AZN stock, worth $968,163. This represents 0.12% of its overall portfolio holdings.
Number of Shares
13,041
Previous 13,677
4.65%
Holding current value
$968,163
Previous $1.07 Million
19.81%
% of portfolio
0.12%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,366Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.05 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...